A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer’s disease

[1] Burke AD(2019)Diagnosing and treating depression in patients with Alzheimer’s disease Neurol Ther 8 325-350

[2] Goldfarb D(2020)The efficacy of sertraline, escitalopram, and nicergoline in the treatment of depression and apathy in Alzheimer's disease: the Okayama Depression and Apathy Project (ODAP) J Alzheimers Dis 76 769-772

[3] Bollam P(2018)Relationships between cognitive complaints and quality of life in older adults with mild cognitive impairment, mild Alzheimer disease dementia, and normal cognition Alzheimer Dis Assoc Disord 32 276-283

[4] Khokher S(2015)Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death: the Cache County Dementia Progression Study Am J Psychiatry 172 460-465

[5] Takemoto M(1990)Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease Am J Psychiatry 147 1049-1051

[6] Ohta Y(2007)American Psychiatric Association practice guideline for the treatment of patients with Alzheimer’s disease and other dementias Second edition Am J Psychiatry 164 5-56

[7] Hishikawa N(2000)Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer’s disease: initial results from the Depression in Alzheimer’s Disease study Am J Psychiatry 157 1686-1689

[8] Yamashita T(2010)Sertraline for the treatment of depression in Alzheimer disease Am J Geriatr Psychiatry 18 136-145

[9] Nomura E(2010)Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes Am J Geriatr Psychiatry 18 332-340

[10] Tsunoda K(2018)Antidepressants for treating depression in dementia Cochrane Database Syst Rev 8 Cd003944-909

[1] Burke AD(2019)Diagnosing and treating depression in patients with Alzheimer’s disease Neurol Ther 8 325-350

[2] Goldfarb D(2020)The efficacy of sertraline, escitalopram, and nicergoline in the treatment of depression and apathy in Alzheimer's disease: the Okayama Depression and Apathy Project (ODAP) J Alzheimers Dis 76 769-772

[3] Bollam P(2018)Relationships between cognitive complaints and quality of life in older adults with mild cognitive impairment, mild Alzheimer disease dementia, and normal cognition Alzheimer Dis Assoc Disord 32 276-283

[4] Khokher S(2015)Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death: the Cache County Dementia Progression Study Am J Psychiatry 172 460-465

[5] Takemoto M(1990)Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease Am J Psychiatry 147 1049-1051

[6] Ohta Y(2007)American Psychiatric Association practice guideline for the treatment of patients with Alzheimer’s disease and other dementias Second edition Am J Psychiatry 164 5-56

[7] Hishikawa N(2000)Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer’s disease: initial results from the Depression in Alzheimer’s Disease study Am J Psychiatry 157 1686-1689

[8] Yamashita T(2010)Sertraline for the treatment of depression in Alzheimer disease Am J Geriatr Psychiatry 18 136-145

[9] Nomura E(2010)Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes Am J Geriatr Psychiatry 18 332-340

[10] Tsunoda K(2018)Antidepressants for treating depression in dementia Cochrane Database Syst Rev 8 Cd003944-909